Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 38.63B | 37.58B | 35.48B | 32.77B | 16.81B | 13.59B |
Gross Profit | 4.89B | 4.83B | 7.43B | 4.62B | -3.00M | -2.98B |
EBITDA | 4.46B | 4.66B | 5.30B | 3.73B | 92.00M | -3.66B |
Net Income | 1.77B | 1.38B | 1.67B | 791.00M | -2.19B | -6.77B |
Balance Sheet | ||||||
Total Assets | 48.14B | 47.05B | 45.32B | 43.34B | 42.54B | 39.48B |
Cash, Cash Equivalents and Short-Term Investments | 8.59B | 8.49B | 8.27B | 8.30B | 7.60B | 5.38B |
Total Debt | 0.00 | 14.23B | 13.95B | 15.17B | 16.69B | 15.38B |
Total Liabilities | 37.80B | 35.46B | 35.61B | 34.86B | 38.05B | 38.10B |
Stockholders Equity | 10.29B | 11.54B | 9.66B | 8.40B | 4.45B | 1.35B |
Cash Flow | ||||||
Free Cash Flow | 120.00M | -6.00M | 895.00M | 2.66B | -700.00M | -3.58B |
Operating Cash Flow | 3.88B | 3.89B | 4.95B | 5.17B | 618.00M | -2.33B |
Investing Cash Flow | -2.85B | -2.33B | -2.98B | -3.44B | -3.02B | -2.34B |
Financing Cash Flow | -947.00M | -1.45B | -2.07B | -2.27B | 2.87B | 5.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $32.47B | 15.49 | 27.12% | 1.29% | 10.61% | 37.32% | |
81 Outperform | $38.16B | 8.48 | 30.07% | 1.07% | 3.01% | -0.90% | |
80 Outperform | $31.88B | 9.87 | 27.70% | ― | 4.23% | 13.13% | |
74 Outperform | $11.33B | 5.61 | 17.85% | 3.55% | 6.95% | 86.01% | |
62 Neutral | $8.56B | 16.69 | -21.27% | ― | 1.50% | ― | |
56 Neutral | $10.83B | 52.56 | 12.26% | ― | 0.00% | 0.00% | |
49 Neutral | $16.13B | 46.20 | 4.30% | 2.32% | 1.64% | 284.24% |